Preanalytical aspects and sample quality assessment in metabolomics studies of human blood

Clinical Chemistry

Volumn 59, Issue 5, 2013, Pages 833-845

  Yin, Peiyuan ^a   Peter, Andreas ^b,c   Franken, Holger ^c   Zhao, Xinjie ^a   Neukamm, Sabine S ^b,c   Rosenbaum, Lars ^c   Lucio, Marianna ^d   Zell, Andreas ^c   Häring, Hans Ulrich ^b,c   Xu, Guowang ^a   Lehmann, Rainer ^b,c  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; HYPOXANTHINE; SPHINGOSINE 1 PHOSPHATE;

ARTICLE; BLOOD; BLOOD COLLECTION TUBE; BLOOD SAMPLING; CENTRIFUGATION; HEMOLYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL DEVICE; METABOLOMICS; QUALITY CONTROL; ROOM TEMPERATURE;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; HEMOLYSIS; HUMANS; METABOLOME; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; QUALITY CONTROL; SPECIMEN HANDLING; TANDEM MASS SPECTROMETRY;

EID: 84876950001     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.199257     Document Type: Article

References (38)

1. Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem 2012;58:139-47.
2. Want EJ, O'Maille G, Smith CA, Brandon TR, Uritboonthai W, Qin C, et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 2006;78:743-52. (Pubitemid 43228581)
3. Bruce SJ, Jonsson P, Antti H, Cloarec O, Trygg J, Marklund SL, Moritz T. Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: from extraction to data analysis. Anal Biochem 2008;372:237-49. (Pubitemid 350116776)
4. Bruce SJ, Tavazzi I, Parisod V, Rezzi S, Kochhar S, Guy PA. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal Chem 2009;81:3285-96.
5. Michopoulos F, Lai L, Gika H, Theodoridis G, Wilson I. UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. J Proteome Res 2009;8:2114-21.
6. Gika H, Theodoridis G. Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples. Bioanalysis 2011;3:1647-61.
7. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011;6:1060-83.
8. Carraro P, Zago T, Plebani M. Exploring the initial steps of the testing process: frequency and nature of pre-preanalytic errors. Clin Chem 2012;58:638-42.
9. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006;44:358-65.
10. Szecsi PB, Odum L. Error tracking in a clinical biochemistry laboratory. Clin Chem Lab Med 2009;47:1253-7.
11. Wood JT, Williams JS, Pandarinathan L, Courville A, Keplinger MR, Janero DR, et al. Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters. Clin Chem Lab Med 2008;46:1289-95.
12. Zivkovic AM, Wiest MM, Nguyen UT, Davis R, Watkins SM, German JB. Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics 2009;5:507-16.
13. Shurubor YI, Matson WR, Willett WC, Hankinson SE, Kristal BS. Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC Clin Pathol 2007;7:9.
14. Dunn WB, Broadhurst D, Ellis DI, Brown M, Halsall A, O'Hagan S, et al. A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. Int J Epidemiol 2008;37(Suppl 1):i23-30.
15. Dettmer K, Almstetter MF, Appel IJ, Nurnberger N, Schlamberger G, Gronwald W, et al. Comparison of serum versus plasma collection in gas chromatography-mass spectrometry-based metabolomics. Electrophoresis 2010;31:2365-73.
16. Yu Z, Kastenmuller G, He Y, Belcredi P, Moller G, Prehn C, et al. Differences between human plasma and serum metabolite profiles. PLoS One 2011;6:e21230.
17. Denery JR, Nunes AA, Dickerson TJ. Characterization of differences between blood sample matrices in untargeted metabolomics. Anal Chem 2011;83:1040-7.
18. Rosenling T, Stoop MP, Smolinska A, Muilwijk B, Coulier L, Shi S, et al. The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid. Clin Chem 2011;57:1703-11.
19. Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR 2011;49:231-43.
20. Chen J, Zhao X, Fritsche J, Yin P, Schmitt-Kopplin P, Wang W, et al. Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal Chem 2008;80:1280-9. (Pubitemid 351272366)
21. Yin P, Wan D, Zhao C, Chen J, Zhao X, Wang W, et al. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol Biosyst 2009;5:868-76.
22. Hodson MP, Dear GJ, Roberts AD, Haylock CL, Ball RJ, Plumb RS, et al. A gender-specific discriminator in Sprague-Dawley rat urine: the deployment of a metabolic profiling strategy for biomarker discovery and identification. Anal Biochem 2007;362:182-92. (Pubitemid 46227324)
23. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 2006;78:567-74. (Pubitemid 43100391)
24. Boyanton BL Jr, Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002;48:2242-7. (Pubitemid 35397569)
25. Deprez S, Sweatman BC, Connor SC, Haselden JN, Waterfield CJ. Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles. J Pharm Biomed Anal 2002;30:1297-310. (Pubitemid 35284339)
26. Bando K, Kawahara R, Kunimatsu T, Sakai J, Kimura J, Funabashi H, et al. Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. J Biosci Bioeng 2010;110:491-9.
27. Dudzinska W, Hlynczak AJ, Skotnicka E, Suska M. The purine metabolism of human erythrocytes. Biochemistry 2006;71:467-75. (Pubitemid 43814006)
28. Yatomi Y. Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta 2008;1780:606-11.
29. Hanel P, Andreani P, Graler MH. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 2007;21:1202-9. (Pubitemid 46495709)
30. Nordstrom A, O'Maille G, Qin C, Siuzdak G. Non-linear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. Anal Chem 2006;78:3289-95.
31. Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, Meitinger T. et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 2008;4:e1000282.
32. Chorell E, Moritz T, Branth S, Antti H, Svensson M. A predictive metabolomics evaluation of nutrition-modulated metabolic stress responses in human blood serum during the early recovery phase of strenuous physical exercise. J Proteome Res 2009;8:2966-77.
33. Chen J, Zhang X, Cao R, Lu X, Zhao S, Fekete A, et al. Serum 27-nor-5beta-cholestane-3,7,12, 24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer. J Proteome Res 2011;10:2625-32.
34. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764-72. (Pubitemid 351821645)
35. Rashed MS, Rahbeeni Z, Ozand PT. Application of electrospray tandem mass spectrometry to neonatal screening. Semin Perinatol 1999;23:183-93. (Pubitemid 29211012)
36. Michopoulos F, Theodoridis G, Smith CJ, Wilson ID. Metabolite profiles from dried biofluid spots for metabonomic studies using UPLC combined with oaToF-MS. J Proteome Res 2010;9:3328-34.
37. Brauer R, Leichtle A, Fiedler G, Thiery J, Ceglarek U. Preanalytical standardization of amino acids and acylcarnitine metabolite profiling in human blood using tandem mass spectrometry. Metabolomics 2011;7:344-52.
38. Huang L, Gough PC, Defelippis MR. Characterization of poly(ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines. Anal Chem 2009;81:567-77.